3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Exercise
36
Nutritional Status
5
Control Groups
4
Resistance Training
3
High-Intensity Interval Training
3
lime
2
Vitamin D
2
Standard of Care
2
Preoperative Exercise
2
Dosage Forms
2
Diet
2
tislelizumab
1
pembrolizumab
1
oncomodulin
1
diacetamate
1
blueberry extract
1
beta-Glucans
1
Whey Proteins
1
Wearable Electronic Devices
1
Walking
1
Transcranial Direct Current Stimulation
1
Tea
1
Tablets
1
TEMPO
1
Spermine Synthase
1
Roflumilast
1
Rehabilitation
1
Radiotherapy
1
Probiotics
1
Physical Therapy Modalities
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Motor Activity
×
Nadolol
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled